Archives
-
3D-Printed TCP Scaffolds for Local EGCG Delivery
2026-09-30
This study developed three-dimensional printed tricalcium phosphate scaffolds that release EGCG locally while supporting osteogenic, vascular, anti-osteoclastogenic, and tumor-suppressive responses in vitro. Its main practical implication is a multifunctional scaffold concept for low-load-bearing craniofacial defects after trauma or tumor excision, although the findings remain preclinical.
-
Guanabenz Acetate: α2-Adrenergic Signaling
2026-09-30
Guanabenz Acetate is an α2-adrenergic receptor agonist with reported activity at α2a, α2b, and α2c subtypes. Its defined receptor profile, DMSO solubility, and storage requirements support controlled GPCR signaling and neuroscience receptor research, while current SARS-CoV-2 evidence provides a mechanistic context rather than proof of antiviral activity.
-
Rapamycin (Sirolimus) Experimental Workflows
2026-09-29
Build reproducible mTOR perturbation assays with Rapamycin (Sirolimus), from concentration-response studies to time-resolved signaling and mitochondrial disease models. This guide connects practical handling, pathway-specific readouts, and the reference study’s proximity-triggered protein synthesis strategy while separating rapamycin use from rapalog-dependent protein engineering.
-
From ALOX5 Signals to Translational Proof
2026-09-29
The ALOX5–ferroptosis–CRSwNP research framework shows why sensitive protein measurements matter after multi-omics discovery. This thought-leadership analysis explains how the SuperSignal ECL Chemiluminescent Substrate Detection Kit (Ultrasensitive) can support Western blot protein detection, quantitative validation, and more disciplined translational decisions without overstating what a signal can prove.
-
Continuous In Situ tRNA Synthesis in PURE
2026-09-28
The reference study establishes continuous in situ production of a complete 21-tRNA set in the PURE recombinant cell-free translation system. By combining optimized transcription designs with post-transcriptional processing and microfluidic chemostats, the authors sustained steady-state protein expression for up to 20 hours, addressing a central requirement for self-regenerating biochemical systems.
-
Annexin V-FITC/PI Apoptosis Assay Kit for RPE
2026-09-28
Use dual Annexin V-FITC and PI staining to distinguish viable, early apoptotic, and membrane-compromised retinal pigment epithelial cells in oxidative-stress experiments. This workflow connects the caffeine–ARPE-19 findings to practical assay design, controls, and troubleshooting without treating fluorescence as a stand-alone mechanism readout.
-
EZ Cap™ SaCas9 mRNA: Delivery Evidence and Limits
2026-09-27
EZ Cap™ SaCas9 mRNA (R1127) is identified on the APExBIO product page, but the available product information does not specify its sequence, cap chemistry, concentration, or formulation. A lung-targeting lipid study reports strong mouse LNP delivery benchmarks, but those findings do not establish that R1127 was tested or that it is compatible with the study’s lead lipid.
-
Indomethacin: Practical Research Workflow Guide
2026-09-26
Indomethacin (SKU A8449) is a nonsteroidal anti-inflammatory drug for experiments examining cyclooxygenase activity, PPAR signaling, and membrane-associated effects. This guide covers preparation and assay controls; it is for in vitro research planning, not a clinical dosing guide or a substitute for validating conditions in a specific model.
-
SmD2 Acetylation Links Splicing to PARP Inhibitor Response
2026-09-25
A 2024 study identifies SmD2 acetylation as a regulatory link between spliceosome activity, BRCA1/FANC cassette-exon expression, and DNA damage repair in hepatocellular carcinoma. SmD2 depletion sensitized HCC models to PARP inhibition, while combining romidepsin with olaparib showed preclinical activity, supporting further study of spliceosome regulation as a route to DNA repair deficiency targeting.
-
SARS-CoV-2 N Protein Sequesters GADD34 mRNA
2026-09-25
Liu and colleagues report that SARS-CoV-2 nucleocapsid protein promotes atypical N+/G3BP1+ foci that sequester GADD34 mRNA, reducing GADD34 expression and weakening IRF3-dependent interferon responses. The findings connect stress-granule-like structures to a specific immune-evasion mechanism and suggest experimental readouts for studying this pathway, while leaving important questions about its operation during infection and across cell types.
-
Dabigatran Etexilate: Review of Oral Thrombin Inhibition
2026-09-24
Blommel and Blommel review dabigatran etexilate as an orally administered prodrug of a reversible, direct thrombin inhibitor, emphasizing its predictable anticoagulant effects and the clinical settings in which it had shown efficacy. The review’s practical contribution is to connect mechanism and pharmacokinetics with potential advantages over vitamin K antagonists and low-molecular-weight heparins, while underscoring bleeding risk and the need to account for renal function.
-
Repaglinide: Interpreting Metabolic Effects in Research
2026-09-24
Repaglinide is a short-acting insulin secretagogue whose effects should be interpreted in the context of pancreatic beta-cell physiology—not assumed to explain DNA repair or leukemia biology. This article connects its established pharmacology with a recent study of energy stress in AML and outlines practical controls for keeping those experimental questions distinct.
-
Systemic PTEN mRNA Delivery Reverses Trastuzumab Resistance
2026-09-23
The study describes a tumor-microenvironment-responsive nanoparticle designed to deliver PTEN mRNA systemically and restore a tumor-suppressive signal in trastuzumab-resistant HER2-positive breast cancer. Its central finding is that PTEN restoration can inhibit PI3K/Akt signaling and improve the response to trastuzumab in the reported models, while the delivery strategy addresses barriers to getting mRNA into tumor cells.
-
Erlotinib Workflows for EGFR–SCUBE3 Research
2026-09-23
Build reproducible EGFR target-engagement, proliferation, and apoptosis assays with Erlotinib, also known as NSC 718781. The workflow positions EGFR inhibition as a mechanistic comparator for SCUBE3-driven signaling, therapy resistance, and immune-suppressive phenotypes rather than treating Erlotinib as a direct SCUBE3 inhibitor.
-
EdU Imaging Kits (HF594): Practical Protocol Guide
2026-09-22
EdU Imaging Kits (HF594) measure S-phase DNA synthesis through 5-ethynyl-2’-deoxyuridine incorporation and HyperFluor™ 594 click-chemistry detection. This guide covers fixed-cell fluorescence microscopy and flow cytometry workflows, while clarifying that the assay is not a direct measure of all proliferation events or a live-cell imaging method.